Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2005-4-21
pubmed:abstractText
Although IL-10 acts as an inhibitory cytokine for APC and CD4(+) T cell function, its effects on CD8(+) T cells are unclear. Additionally, little is known about whether initial priming in the presence of IL-10 can have long-lasting effects and influence subsequent CD8(+) T cell responses that occur in the absence of the cytokine. In the present study, we clarified the role of IL-10 during primary responses and examined whether exposure to IL-10 during initial priming of CD8(+) T cells impacted secondary responses. To determine the effect of IL-10 on Ag-specific T cell responses, peptide-pulsed IL-10R2(-/-) splenic dendritic cells were used to prime T cells from OT-I CD8(+) TCR transgenic mice. During the primary response, the presence of IL-10 resulted in enhancement of CD8(+) T cell numbers without detectable alterations in the kinetics or percentage of cells that underwent proliferation. A modest increase in survival, not attributable to Bcl-2 or Bcl-x(L), was also observed with IL-10 treatment. Other parameters of CD8(+) T cell function, including IL-2, IFN-gamma, TNF-alpha, and granzyme production, were unaltered. In contrast, initial exposure to IL-10 during the primary response resulted in decreased OT-I expansion during secondary stimulation. This was accompanied by lowered IL-2 levels and reduced percentages of proliferating BrdU(+) cells and OT-I cells that were CD25(high). IFN-gamma, TNF-alpha, and granzyme production were unaltered. These data suggest that initial exposure of CD8(+) T cells to IL-10 may be temporarily stimulatory; however, programming of the cells may be altered, resulting in diminished overall responses.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5382-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15843536-Adjuvants, Immunologic, pubmed-meshheading:15843536-Animals, pubmed-meshheading:15843536-CD8-Positive T-Lymphocytes, pubmed-meshheading:15843536-Cell Proliferation, pubmed-meshheading:15843536-Cell Survival, pubmed-meshheading:15843536-Cells, Cultured, pubmed-meshheading:15843536-Cytokines, pubmed-meshheading:15843536-Dendritic Cells, pubmed-meshheading:15843536-Down-Regulation, pubmed-meshheading:15843536-Female, pubmed-meshheading:15843536-Immunization, Secondary, pubmed-meshheading:15843536-Immunophenotyping, pubmed-meshheading:15843536-Interleukin-10, pubmed-meshheading:15843536-Interleukin-2, pubmed-meshheading:15843536-Intracellular Fluid, pubmed-meshheading:15843536-Lymphocyte Activation, pubmed-meshheading:15843536-Male, pubmed-meshheading:15843536-Mice, pubmed-meshheading:15843536-Mice, Inbred C57BL, pubmed-meshheading:15843536-Mice, Knockout, pubmed-meshheading:15843536-Mice, Transgenic, pubmed-meshheading:15843536-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:15843536-Receptors, Interleukin-2, pubmed-meshheading:15843536-Serine Endopeptidases, pubmed-meshheading:15843536-bcl-X Protein
pubmed:year
2005
pubmed:articleTitle
Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses.
pubmed:affiliation
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't